Discover the power of gut microbiome tests for wellness and longevity

• by Devi Shastri

• November 3, 2025

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

• by Kathryn Wighton

• January 27, 2026

• 3 min

The CT-based attenuation index of peri-bowel adipose tissue can predict disease progression in inflammatory bowel disease patients

• by Jun Lu, Hui Xu, Jingxuan Zhang, Tianxin Cheng, Jing Zheng, Xinjun Han, Yuxin Wang, Xuxu Meng, Xiaoyang Li, Jiahui Jiang, Xue Dong, Zhenchang Wang, Zhenghan Yang, Lixue Xu

• October 22, 2025

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects

• by Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], David Rubin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Isabelle de Kock, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

• July 31, 2025